HUE064474T2 - Gyógyászati kiszerelés - Google Patents
Gyógyászati kiszerelésInfo
- Publication number
- HUE064474T2 HUE064474T2 HUE18715593A HUE18715593A HUE064474T2 HU E064474 T2 HUE064474 T2 HU E064474T2 HU E18715593 A HUE18715593 A HU E18715593A HU E18715593 A HUE18715593 A HU E18715593A HU E064474 T2 HUE064474 T2 HU E064474T2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17163830 | 2017-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE064474T2 true HUE064474T2 (hu) | 2024-03-28 |
Family
ID=58461174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE18715593A HUE064474T2 (hu) | 2017-03-30 | 2018-03-28 | Gyógyászati kiszerelés |
Country Status (21)
Country | Link |
---|---|
US (2) | US11559490B2 (hu) |
EP (2) | EP3601277B1 (hu) |
JP (1) | JP7228524B2 (hu) |
KR (1) | KR20190130017A (hu) |
CN (1) | CN110446707B (hu) |
AU (1) | AU2018246258B2 (hu) |
BR (1) | BR112019020269A2 (hu) |
CA (1) | CA3058286A1 (hu) |
DK (1) | DK3601277T3 (hu) |
FI (1) | FI3601277T3 (hu) |
HR (1) | HRP20231748T1 (hu) |
HU (1) | HUE064474T2 (hu) |
IL (2) | IL301979B1 (hu) |
LT (1) | LT3601277T (hu) |
MX (1) | MX2019011639A (hu) |
PT (1) | PT3601277T (hu) |
RS (1) | RS65052B1 (hu) |
SG (1) | SG11201909062WA (hu) |
SI (1) | SI3601277T1 (hu) |
TW (2) | TWI808077B (hu) |
WO (1) | WO2018178134A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013008118A1 (de) * | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
CN114072396B (zh) * | 2019-06-27 | 2024-02-02 | 南京明德新药研发有限公司 | 作为dna-pk抑制剂的喹啉和噌啉衍生物 |
WO2022058323A1 (en) | 2020-09-18 | 2022-03-24 | Merck Patent Gmbh | Compounds for the treatment of viral infections |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011509283A (ja) | 2008-01-11 | 2011-03-24 | シプラ・リミテッド | 固体医薬剤形 |
EP2105130A1 (de) * | 2008-03-25 | 2009-09-30 | Ratiopharm GmbH | Pharmazeutische Formulierung und Verfahren zu deren Herstellung |
WO2012164578A1 (en) | 2011-06-02 | 2012-12-06 | Hetero Research Foundation | Compositions and methods for preparing immediate release formulations of nilotinib |
HUE035247T2 (hu) | 2011-10-14 | 2018-05-02 | Array Biopharma Inc | Szilárd diszperzió |
US20160000720A1 (en) | 2013-02-14 | 2016-01-07 | Aurobindo Pharma Limited | Pharmaceutical compositions comprising Tadalafil |
DE102013008118A1 (de) | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
RU2019123406A (ru) | 2014-02-05 | 2019-10-03 | Мерк Шарп И Доум Корп. | Технология приготовления таблеток для cgrp-активных соединений |
EP2913048A1 (en) | 2014-02-27 | 2015-09-02 | ratiopharm GmbH | Pharmaceutical composition comprising trametinib |
JP6203702B2 (ja) | 2014-11-18 | 2017-09-27 | 信越化学工業株式会社 | ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法 |
-
2018
- 2018-03-28 SI SI201831045T patent/SI3601277T1/sl unknown
- 2018-03-28 AU AU2018246258A patent/AU2018246258B2/en active Active
- 2018-03-28 CA CA3058286A patent/CA3058286A1/en active Pending
- 2018-03-28 IL IL301979A patent/IL301979B1/en unknown
- 2018-03-28 PT PT187155932T patent/PT3601277T/pt unknown
- 2018-03-28 LT LTEPPCT/EP2018/057877T patent/LT3601277T/lt unknown
- 2018-03-28 BR BR112019020269A patent/BR112019020269A2/pt active Search and Examination
- 2018-03-28 EP EP18715593.2A patent/EP3601277B1/en active Active
- 2018-03-28 DK DK18715593.2T patent/DK3601277T3/da active
- 2018-03-28 CN CN201880022126.5A patent/CN110446707B/zh active Active
- 2018-03-28 JP JP2019553415A patent/JP7228524B2/ja active Active
- 2018-03-28 HU HUE18715593A patent/HUE064474T2/hu unknown
- 2018-03-28 RS RS20240029A patent/RS65052B1/sr unknown
- 2018-03-28 US US16/498,943 patent/US11559490B2/en active Active
- 2018-03-28 IL IL269668A patent/IL269668B2/en unknown
- 2018-03-28 SG SG11201909062W patent/SG11201909062WA/en unknown
- 2018-03-28 KR KR1020197032000A patent/KR20190130017A/ko not_active Application Discontinuation
- 2018-03-28 WO PCT/EP2018/057877 patent/WO2018178134A1/en active Application Filing
- 2018-03-28 FI FIEP18715593.2T patent/FI3601277T3/fi active
- 2018-03-28 HR HRP20231748TT patent/HRP20231748T1/hr unknown
- 2018-03-28 EP EP23202392.9A patent/EP4286007A3/en active Pending
- 2018-03-28 MX MX2019011639A patent/MX2019011639A/es unknown
- 2018-03-30 TW TW107111175A patent/TWI808077B/zh active
- 2018-03-30 TW TW112122367A patent/TW202402297A/zh unknown
-
2022
- 2022-12-01 US US18/060,929 patent/US20230119567A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201807942D0 (en) | Pharmaceutical formulation | |
IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
ZA201903101B (en) | Pharmaceutical formulations | |
IL271226A (en) | medical preparation | |
IL271759A (en) | Pharmaceutical preparations that include anthraxtinib | |
PT3426294T (pt) | Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina | |
ZA202102871B (en) | Pharmaceutical formulation | |
IL253177B (en) | Pharmacy preparation | |
IL269239A (en) | A pharmaceutical combination containing fonsimod | |
IL278927A (en) | pharmaceutical preparation | |
HK1245653A1 (zh) | 藥物製劑 | |
IL266537A (en) | pharmaceutical preparation | |
ZA201807851B (en) | Pharmaceutical formulation | |
FI3601277T3 (fi) | Farmaseuttinen formulaatio | |
EP3383371A4 (en) | PHARMACEUTICAL FORMULATION | |
GB201506755D0 (en) | Novel pharmaceutical formulation | |
EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
IL275144A (en) | Pharmacy preparation | |
GB201511246D0 (en) | Pharmaceutical formulation | |
IL271908A (en) | Over-compressed pharmaceutical preparations | |
GB201719873D0 (en) | Pharmaceutical formulation | |
GB201604545D0 (en) | Novel pharmaceutical formulation | |
GB201610440D0 (en) | Pharmaceutical formulations |